Back to Search
Start Over
Supplementary Figure 6 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 312KB, Efficacy of AZD9291 in H3255, PC-9VanR and A431 xenograft models. Weight loss data for chronically dosed AZD9291 in PC-9 and H1975 xenograft models.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....754faf19a9b9f1fe62df9a5795c6cab6
- Full Text :
- https://doi.org/10.1158/2159-8290.22532195